Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood hodgkin disease
Authors:
- H. van Den BergHBH. van Den Berg
- F. FurstnerFFF. Furstner
- C. van Den BosCBC. van Den Bos
- H. BehrendtHBH. Behrendt
- 30 October 2003
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 42 (3) , 210-215
Abstract
Background: Children treated for Hodgkin disease are at risk for gonadal damage. Since most children were treated with radiotherapy (RT) in combination with chemotherapy, the presumed detrimental effect of MOPP (mustine, vincristine, procarbazine, and prednisone) (in contrast to schemes with less or without alkylating agents) could not be discerned completely from the effects of RT.Procedures: Children with Hodgkins disease treated without RT were included in sequential protocols containing six courses of MOPP (n = 24), six courses of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) (n = 17), or three courses of MOPP/ABVD (n = 35). Of these 76 patients, 48, who had completed treatment and had reached puberty, were investigated for gonadal damage.Results: Of the male patients, 81% of MOPP treated patients had increased follicular stimulating hormone (FSH) values, in 23% luteinizing hormone (LH) values were abnormal. In ABVD treated patients, no elevated levels of FSH or LH were noted. In 30% of patients treated with MOPP/ABVD, FSH values were abnormal, but no abnormal LH values were found. Median testicular volume per group decreased in relation to a higher number of MOPP courses. Sperm analysis revealed azoospermia in nearly all MOPP treated patients. In ABVD and MOPP/ABVD treated patients both oligospermia and azoospermia were noted. The number of sperm samples were too less to make any sound conclusions. Menarche occurred in all females, however in some at a relatively later age. One female patient treated with MOPP/ABVD had a normal pregnancy.Conclusions: Limitation of MOPP therapy to three courses, in children treated without any RT, results in less gonadal damage as compared with six MOPP courses. From our data, MOPP damages Sertoli cells and may also damage Leydig cells as suggested by the higher LH values in conjunction with normal testosterone levels.Keywords
This publication has 48 references indexed in Scilit:
- Irreversible gonadal damage in male survivors of pediatric Hodgkin's diseaseCancer, 1996
- Gonadal function following chemotherapy for childhood Hodgkin's diseaseMedical and Pediatric Oncology, 1996
- Luteinizing hormone pulsatility and computer-assisted analysis of sperm features in patients with Hodgkin's diseaseJournal of Cancer Research and Clinical Oncology, 1996
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996
- Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphomaAnnals of Hematology, 1994
- Pediatric hodgkin's disease in costa rica: Twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomyMedical and Pediatric Oncology, 1994
- Results of a changing treatment philosophy for children with stage I Hodgkin's disease: A 35-year experienceMedical and Pediatric Oncology, 1991
- Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVDEuropean Journal of Cancer and Clinical Oncology, 1985
- ABVD chemotherapy in the treatment of Hodgkin's diseaseCancer Treatment Reviews, 1982
- CHEMOTHERAPY OF CHILDHOOD HODGKIN'S DISEASE IN UGANDAThe Lancet, 1972